4Peterson J G, Topol E J, Sapp S K, et al. Evaluation of the effects of aspirin combined with angiotensin-coverting enzyme inhibitors in patients with coronary artery disease[J]. Am J Med, 2000,109(5):371-377.
5Leor J, Reicher-Reiss H, Goldbourt U, et al. Aspirin and mortality in patients treated with angiotensin-coverting enzyme inhibitors: a cohort study of 11 575 patients with coronary artery disease[J]. J Am Coll Cardiol, 1999,33 (7):1920- 1925.
6Krombach R S,Clair M J, Hendrick J W,et al. Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns[J]. Cardiovasc Res, 1998,38(3) : 631-645.
7Swedberg K, Pfeffer M, Granger C, et al. Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators[J]. J Card Fail,1999,5(3):276-282.
8McKelvie R S, Yusuf S, Pericak D, et al. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators[J]. Circulation, 1999,100 (10) : 1056-1064.
